Refills

DEA Policy Statement: Dispensing Controlled Substances for the Treatment of Pain
Description: 
This 2006 document explains the Drug Enforcement Agency's (DEA) role in regulation of controlled substances and the physician's legal responsibility to prescribe controlled substances for legitimate medical purposes.
Source: 
Drug Enforcement Agency (DEA)
4.333335
Your rating: None Average: 4.3 (3 votes)
Tags:
Diversion and Abuse of Buprenorphine: A Brief Assessment of Emerging Indicators
Description: 
This report by SAMHSA addresses the issues of buprenorphine diversion and abuse of which have developed in recent years. The report gives a summary of the findings on diversion and abuse and recommendations for the future.
Source: 
Substance Abuse and Mental Health Services Administration (SAMHSA)
4.333335
Your rating: None Average: 4.3 (3 votes)
Tags:
Practitioner's Manual: An Informational Outline of the Controlled Substances Act
Description: 
Manual written by the DEA to assist physicians in understanding and complying with the Federal Controlled Substances Act. Topics covered include recordkeeping requirements, rules regarding prescription, and security requirements.
Source: 
US Drug Enforcement Administration (DEA)
4.666665
Your rating: None Average: 4.7 (3 votes)
Tags:
Syndicate content